{"transactions":[{"id":834403,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-18T20:07:20.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":15610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 16, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":15610,"derivative":{"exercise_price":7.64,"expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":15610},"source":{"system":"sec-edgar","filing":"0001987062-26-000002","document":"form4-03182026_080313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000198706226000002/form4-03182026_080313.xml","form_type":"4"}},{"id":940682,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-01-12T21:03:14.000Z","date":"2026-01-08","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"50% of the total RSUs will vest on January 8, 2026 and the remaining 50% of the RSUs will vest on January 8, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"50% of the total RSUs will vest on January 8, 2026 and the remaining 50% of the RSUs will vest on January 8, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001987062-26-000001","document":"form4-01122026_090110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000198706226000001/form4-01122026_090110.xml","form_type":"4"}},{"id":940681,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-01-12T21:03:14.000Z","date":"2026-01-08","kind":"sale","planned":false,"acquired":false,"shares":2062,"price":18.4394,"value":38022.0428,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold as part of a block trade for multiple security holders of the Issuer in multiple transactions at prices ranging from $18.13 to $19.3061 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 with regard to the block trade."}],"balance_after":5402,"source":{"system":"sec-edgar","filing":"0001987062-26-000001","document":"form4-01122026_090110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000198706226000001/form4-01122026_090110.xml","form_type":"4"}},{"id":940680,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-01-12T21:03:14.000Z","date":"2026-01-08","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 200 shares acquired on May 15, 2025 and 200 shares acquired on November 15, 2025 under the 2020 Employee Stock Purchase Plan."}],"balance_after":7464,"source":{"system":"sec-edgar","filing":"0001987062-26-000001","document":"form4-01122026_090110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000198706226000001/form4-01122026_090110.xml","form_type":"4"}},{"id":957838,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-12-29T21:15:26.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the total RSUs will vest on January 8, 2026 and the remaining 50% of the RSUs will vest on January 8, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the total RSUs will vest on January 8, 2026 and the remaining 50% of the RSUs will vest on January 8, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001987062-25-000002","document":"form4-12292025_091215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000198706225000002/form4-12292025_091215.xml","form_type":"4"}},{"id":1198214,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T21:12:20.000Z","date":"2025-03-15","kind":"grant","planned":false,"acquired":true,"shares":278386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":278386,"derivative":{"exercise_price":0.387,"expiration_date":"2035-03-15","underlying":"Common Stock","underlying_shares":278386},"source":{"system":"sec-edgar","filing":"0001415889-25-008443","document":"form4-03182025_090317.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588925008443/form4-03182025_090317.xml","form_type":"4"}},{"id":1271027,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T21:21:37.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs vested on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs vested on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-25-003728","document":"form4-02122025_090233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588925003728/form4-02122025_090233.xml","form_type":"4"}},{"id":1271026,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-12T21:21:37.000Z","date":"2025-02-11","kind":"sale","planned":false,"acquired":false,"shares":3183,"price":0.5296,"value":1685.7168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold as part of a block trade for multiple security holders of the Issuer in multiple transactions at prices ranging from $0.51 to $0.58 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 with regard to the block trade."}],"balance_after":41283,"source":{"system":"sec-edgar","filing":"0001415889-25-003728","document":"form4-02122025_090233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588925003728/form4-02122025_090233.xml","form_type":"4"}},{"id":1271025,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-12T21:21:37.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,000 shares acquired on May 16, 2024 and 4,000 shares acquired on November 16, 2024 under the 2020 Employee Stock Purchase Plan."}],"balance_after":44466,"source":{"system":"sec-edgar","filing":"0001415889-25-003728","document":"form4-02122025_090233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588925003728/form4-02122025_090233.xml","form_type":"4"}},{"id":1566988,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-19T20:11:04.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":227000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":227000,"derivative":{"exercise_price":1.5,"underlying":"Common Stock","underlying_shares":227000},"source":{"system":"sec-edgar","filing":"0001415889-24-008495","document":"form4-03192024_080352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588924008495/form4-03192024_080352.xml","form_type":"4"}},{"id":1645241,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, INTERIM CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-14T00:36:54.000Z","date":"2024-02-10","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":8000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001415889-24-003640","document":"form4-02142024_120246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588924003640/form4-02142024_120246.xml","form_type":"4"}},{"id":1645240,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, INTERIM CFO"}}],"security":"Common Stock","published_at":"2024-02-14T00:36:54.000Z","date":"2024-02-13","kind":"sale","planned":false,"acquired":false,"shares":1470,"price":0.97,"value":1425.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."}],"balance_after":28466,"source":{"system":"sec-edgar","filing":"0001415889-24-003640","document":"form4-02142024_120246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588924003640/form4-02142024_120246.xml","form_type":"4"}},{"id":1645239,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, INTERIM CFO"}}],"security":"Common Stock","published_at":"2024-02-14T00:36:54.000Z","date":"2024-02-10","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":29936,"source":{"system":"sec-edgar","filing":"0001415889-24-003640","document":"form4-02142024_120246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000141588924003640/form4-02142024_120246.xml","form_type":"4"}},{"id":1690555,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Interim CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-01-03T21:20:30.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the total restricted stock units vested on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"100% of the total restricted stock units vested on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-24-000367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919124000367/doc4.xml","form_type":"4"}},{"id":1690554,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Interim CFO"}}],"security":"Common Stock","published_at":"2024-01-03T21:20:30.000Z","date":"2024-01-02","kind":"sale","planned":false,"acquired":false,"shares":10672,"price":0.91,"value":9711.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."}],"balance_after":25936,"source":{"system":"sec-edgar","filing":"0001209191-24-000367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919124000367/doc4.xml","form_type":"4"}},{"id":1690553,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Interim CFO"}}],"security":"Common Stock","published_at":"2024-01-03T21:20:30.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,082 shares acquired on May 13, 2022 and 3,526 shares acquired on November 15, 2023 under the 2020 Employee Stock Purchase Plan."}],"balance_after":36608,"source":{"system":"sec-edgar","filing":"0001209191-24-000367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919124000367/doc4.xml","form_type":"4"}},{"id":1821291,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":57813,"kind":"person","name":"Borthwick Kathleen","position":1,"cik":"0001987062","reported_name":"Borthwick Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Interim CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-28T22:34:32.000Z","date":"2023-07-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested as to 25% of the total shares on July 28, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":0.8773,"expiration_date":"2033-07-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-043725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787297/000120919123043725/doc4.xml","form_type":"4"}}]}